We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 1,268

IOM report on salt recommendations draws criticism

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 17 2013

The Institute of Medicine (IOM) recently issued a report assessing the scientific evidence behind government recommendations that adults in the

EFSA and ECDC issue report on antimicrobial resistant bacteria

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • May 17 2013

The European Food Safety Authority (EFSA) and European Centre for Disease Control and Prevention (ECDC) have issued their third joint report "on

EFSA reduces TDI for phenol

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • May 17 2013

The European Food Safety Authority (EFSA) has lowered the tolerable daily intake (TDI) of phenola chemical used to make coatings, adhesives

New studies focus on sodium and calorie content of restaurant and processed foods

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 17 2013

Three recent studies published in JAMA Internal Medicine have analyzed the nutritional content of restaurant and processed foods, raising questions

Putative class alleges pharma statements about new drug violated securities laws

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

Aveo Pharmaceuticals, Inc. and several of its executives have been targeted in a securities class action filed in a federal court in Massachusetts

News Bytes - May 16, 2013

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

The National Institutes of Health (NIH) Office of Biotechnology Activities proposes revising the "NIH Guidelines for Research Involving Recombinant

Congress advances pharma supply chain and animal-drug user-fee laws

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

The House Energy and Commerce Subcommittee on Health has reportedly approved draft legislation that would change the existing lot-level

Biotech receives $32.5 million for cancer research

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

Celator Pharmaceuticals, Inc., a Princeton, New Jersey-based company that develops cancer therapies, has raised $32.5 million in the final closing of

EU Medicines Agency plans to appeal interim rulings on release of clinical trial data

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • May 16 2013

According to a news source, European Medicines Agency (EMA) Director Guido Rasi intends to appeal interim rulings recently issued by the European

NASDAQ Biotechnology Index surpasses all-time high in 1Q13

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

The NASDAQ Biotechnology Index reportedly rose in the first quarter of 2013 (1Q13) above levels last seen during the 2000 genomics bubble peakthe

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy